MedPath

Clasic Laryngeal Mask Airway(C-LMA) and I-gel Releated Regurgitation and Complications

Phase 4
Conditions
Bladder Tumour
Prostate Hyperplasia
Registration Number
NCT01876836
Lead Sponsor
Diskapi Yildirim Beyazit Education and Research Hospital
Brief Summary

1. i-gel

2. C-LMA

Compare the effect on gastroeosephageal reflux Postoperative complicatios.

Detailed Description

120 ASA I-II adult patients. Patients were randomised into two groups

1. i-gel

2. C-LMA Volume controlled ventilation, general anesthesia Asses Gastroeosephageal reflux, sore throat, coughing, dysphagia,dysphonia recorded.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
120
Inclusion Criteria
  • ASA I-II
  • Adult
  • Elective surgery
  • Bladder tumour
  • Prostat hyperplasi
Exclusion Criteria
  • Emergency surgery
  • Hiatal hernia
  • Gastroeosephageal reflux disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Ph MEASUREMENT1 MİNUTE AFTER EXTUBATİON

The ph of the secretions on the airway device will be measurd with a Ph-meter

Secondary Outcome Measures
NameTimeMethod
Bleu dye on the airway device5 min after placenent

The airway device will be examined with fiberoptic endoscope after placement

Trial Locations

Locations (1)

DiskapiYBERH

🇹🇷

Ankara, Altındağ, Turkey

DiskapiYBERH
🇹🇷Ankara, Altındağ, Turkey
Murat Alper, Prof.
Contact
+903125962000
muratalper@hotmail.com
Reyhan Polat, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.